The Centre for Innovation in Regulatory Science (CIRS) is guided by the objectives of its predecessor organisation, the CMR International Institute for Regulatory Science (the Institute), embracing and continuing to fulfil and expand the Institute’s mission and objectives. CIRS is the vehicle through which the international pharmaceutical industry, regulatory authorities and academia meet, debate and develop regulatory policy. The objectives of CIRS are to facilitate dialogue and productive discussions in order to promote better understanding of the science that will form the basis for regulatory policy; to play an active and pro-active role in the evolution and harmonisation of international regulatory requirements and approval procedures to act as a catalyst for the adoption of best practice in global regulatory affairs; to provide a neutral, professional forum through which peers can meet and share best practice; and to pursue research that supports the CIRS mission.

Meaning: 
The Centre for Innovation of Regulatory Science
Type of acronyms: 
Organization
Category of acronyms: 
IFPMA
Alphabets: 
C